Back to Directory

Katie S. McCarthy

Email

kmccarthy@fhi360.org

Phone

(919) 321-3326

Institution

FHI 360

Title

Clinical Research Associate

Address

FHI 360
359 Blackwell St.
Suite 200
Durham, NC 27701
United States of America

Request an Update

Affiliated Studies

IMPAACT 2034: Phase I Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

38754

Research Area

Tuberculosis

Study Status

In Development

P1084s: Maternal Infant TDF Toxicity Safety

DAIDS Number

10790

Research Area

Complications & Comorbidities

Study Status

Closed to Follow Up

P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity

DAIDS Number

10495

Research Area

Treatment

Study Status

Concluded

P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY

DAIDS Number

10765

Research Area

Other

Study Status

Concluded

P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy

DAIDS Number

10661

Research Area

Other

Study Status

Concluded

Show All